Cargando…
Detection and Prediction of Mild Cognitive Impairment in Alzheimer’s Disease Mice
BACKGROUND: The recent failure of clinical trials to treat Alzheimer’s disease (AD) indicates that the current approach of modifying disease is either wrong or is too late to be efficient. Mild cognitive impairment (MCI) denotes the phase between the preclinical phase and clinical overt dementia. AD...
Autores principales: | Rai, Surya Prakash, Bascuñana, Pablo, Brackhan, Mirjam, Krohn, Markus, Möhle, Luisa, Paarmann, Kristin, Pahnke, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683054/ https://www.ncbi.nlm.nih.gov/pubmed/32831204 http://dx.doi.org/10.3233/JAD-200675 |
Ejemplares similares
-
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
por: Bascuñana, Pablo, et al.
Publicado: (2020) -
Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
por: Bascuñana, Pablo, et al.
Publicado: (2023) -
A New Tool for the Analysis of the Effect of Intracerebrally Injected Anti-Amyloid-β Compounds
por: Upīte, Jolanta, et al.
Publicado: (2021) -
Early Cognitive Training Rescues Remote Spatial Memory but Reduces Cognitive Flexibility in Alzheimer’s Disease Mice
por: Rai, Surya Prakash, et al.
Publicado: (2020) -
Machine Learning-Supported Analyses Improve Quantitative Histological Assessments of Amyloid-β Deposits and Activated Microglia
por: Bascuñana, Pablo, et al.
Publicado: (2021)